These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 28867541

  • 1. miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.
    Su SG, Yang M, Zhang MF, Peng QZ, Li MY, Liu LP, Bao SY.
    Int J Biochem Cell Biol; 2017 Oct; 91(Pt A):53-59. PubMed ID: 28867541
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 3. FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma.
    Lin MF, Yang YF, Peng ZP, Zhang MF, Liang JY, Chen W, Liu XH, Zheng YL.
    Int J Biochem Cell Biol; 2017 Jul 30; 88():155-161. PubMed ID: 28506857
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
    Sun W, Zhang Z, Wang J, Shang R, Zhou L, Wang X, Duan J, Ruan B, Gao Y, Dai B, Qu S, Liu W, Ding R, Wang L, Wang D, Dou K.
    Oncotarget; 2016 Mar 08; 7(10):11595-608. PubMed ID: 26871477
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
    Chen WX, Zhang ZG, Ding ZY, Liang HF, Song J, Tan XL, Wu JJ, Li GZ, Zeng Z, Zhang BX, Chen XP.
    Oncotarget; 2016 Apr 19; 7(16):22674-86. PubMed ID: 26993767
    [Abstract] [Full Text] [Related]

  • 6. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y, Wang J, Han J, Luo D, Sun Z.
    Exp Cell Res; 2017 Nov 15; 360(2):210-217. PubMed ID: 28890291
    [Abstract] [Full Text] [Related]

  • 7. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX, Liao R, Pan L, Du CY.
    Immunol Lett; 2017 Aug 15; 188():116-123. PubMed ID: 28668554
    [Abstract] [Full Text] [Related]

  • 8. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
    Wang CH, Guo ZY, Chen ZT, Zhi XT, Li DK, Dong ZR, Chen ZQ, Hu SY, Li T.
    Sci Rep; 2015 Jul 20; 5():12366. PubMed ID: 26190376
    [Abstract] [Full Text] [Related]

  • 9. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y, Jia Y, Li Q, Zhang H, Tu K, Song T, Liu Q.
    Oncotarget; 2016 Jun 14; 7(24):36909-36923. PubMed ID: 27191994
    [Abstract] [Full Text] [Related]

  • 10. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.
    Zhang Y, Zhang D, Jiang J, Dong L.
    Oncol Rep; 2017 Jan 14; 37(1):323-332. PubMed ID: 27878280
    [Abstract] [Full Text] [Related]

  • 11. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 14; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 12. SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis.
    Li J, Li MH, Wang TT, Liu XN, Zhu XT, Dai YZ, Zhai KC, Liu YD, Lin JL, Ge RL, Sun SH, Wang F, Yuan JH.
    Br J Cancer; 2021 Sep 14; 125(6):865-876. PubMed ID: 34274945
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/β-catenin signaling pathway.
    Guo Y, Chen L, Sun C, Yu C.
    Biomed Pharmacother; 2017 Jul 14; 91():13-20. PubMed ID: 28437633
    [Abstract] [Full Text] [Related]

  • 14. HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells.
    Suk FM, Wu CY, Chiu WC, Chien CY, Chen TL, Liao YJ.
    Molecules; 2022 Nov 18; 27(22):. PubMed ID: 36432116
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
    Zhu M, Li M, Wang T, Linghu E, Wu B.
    Tumour Biol; 2016 Oct 18; 37(10):13995-14008. PubMed ID: 27492460
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y, Li F, Zhang X, Liu A, Qi J, Cui H, Zhao P.
    Int J Clin Exp Pathol; 2015 Oct 18; 8(10):12446-54. PubMed ID: 26722431
    [Abstract] [Full Text] [Related]

  • 17. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G, Lin Y, Zhang H, Wu D.
    Biochem Biophys Res Commun; 2015 Jul 31; 463(3):315-21. PubMed ID: 26022123
    [Abstract] [Full Text] [Related]

  • 18. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z.
    Biomed Pharmacother; 2017 Apr 31; 88():421-429. PubMed ID: 28122307
    [Abstract] [Full Text] [Related]

  • 19. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
    Li Q, Ding C, Chen C, Zhang Z, Xiao H, Xie F, Lei L, Chen Y, Mao B, Jiang M, Li J, Wang D, Wang G.
    J Gastroenterol Hepatol; 2014 Apr 31; 29(4):835-42. PubMed ID: 24219032
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
    Peng W, Fan H.
    Biomed Pharmacother; 2016 Oct 31; 83():450-455. PubMed ID: 27427851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.